Stephen V. Faraone, PhD

Department of Psychiatry, Norton College of Medicine, SUNY Upstate Medical University, Syracuse, New York

  • 50Articles
  • 299.4KReads
  • 1998–2025Active
  • 144Collaborators
  • 5.6KCitations

About

Stephen V. Faraone, PhD, is affiliated with the Department of Psychiatry at Norton College of Medicine, SUNY Upstate Medical University in Syracuse, New York. His work, published from 1998 to 2025, covers topics including neurodevelopmental disorders, child and adolescent psychiatry, bipolar disorder, addiction, ADHD, depression, genetics, and mood disorders. He has frequently collaborated with Joseph Biederman, Thomas J. Spencer, Carter R. Petty, Janet Wozniak, and Timothy E. Wilens.

Publications

JCP
Validity of an Online ADHD Assessment in a Real-World Sample of Adults Seeking Web-Based Mental Healthcare
Original Research

Validity of an Online ADHD Assessment in a Real-World Sample of Adults Seeking Web-Based Mental Healthcare

September 8, 2025

The online assessment correctly identified over 80% of ADHD-positive cases. Compared with the clinical interview, the online assessment was more conservative in rendering ADHD-positive diagnoses.
, , , et al
JCP
Estimating the 12-Hour Serum Lithium Level
Original Research

Estimating the 12-Hour Serum Lithium Level

March 3, 2025

Lithium blood tests should be conducted 12 hours after the last lithium dose, but complying with this strict timing is difficult. The authors developed a simple tool to estimate...
, , , et al
JCP
Measuring Executive Function in ADHD With the BRIEF-A
Original Research

Measuring Executive Function in ADHD With the BRIEF-A

November 21, 2022

The BRIEF-A identified executive function deficits in adults with ADHD that added disability beyond that associated with ADHD alone.
, , , et al
JCP
Transdiagnostic PRS Prediction of Mood Disorders
Original Research

Transdiagnostic PRS Prediction of Mood Disorders

April 20, 2022

Mood disorders often co-occur with behavior disorders in children and adolescents. This study explored if polygenic risk scores based on external genome-wide association studies of these disorders could improve...
, , , et al
JCP
Original Research

Efficacy and Safety of AR19 in Adults With ADHD

August 24, 2021

Misuse of stimulant medications prescribed for attention-deficit/hyperactivity disorder (ADHD) can have adverse medical outcomes. This study tested the safety and efficacy of AR19, a manipulation-resistant formulation of amphetamine, in...
, , , et al
JCP
AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD
Insights

AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD

August 24, 2021

AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the...
JCP
Original Research

Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD

June 29, 2021

Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...
, , , et al
JCP
Original Research

Norms for Time-Sensitive Measures of Function in ADHD

December 10, 2019

Children with ADHD often have functional impairments in the early morning and late afternoon and evening. This study sought to establish norms on 2 rating scales to help clinicians...
, , , et al
JCP
Original Research

Predictors of the Persistence and Emergence of ADHD Over a 9-Year Period

May 7, 2019

What factors may predict the onset of ADHD in adolescence? This population-based study used baseline and follow-up phone interviews to identify predictors and evaluate the validity of subthreshold and...
, , , et al
JCP
Meta-Analysis

Sleep-Associated Adverse Events With ADHD Treatment

April 30, 2019

Methylphenidate is related to sleep-related adverse events. This meta-analysis sought to quantify this impact of methylphenidate and determine the varieties of sleep problems associated with this drug.
, , , et al
JCP
Original Research

Subsyndromal ADHD in Children

August 7, 2018

ADHD symptoms tend to emerge over time, meaning that some children will manifest subsyndromal symptoms of ADHD before they meet full diagnostic criteria. Read this article to learn how...
, , , et al
JCP
Original Research

Naltrexone Mitigates Stimulant-Induced Euphoria

March 13, 2018

While stimulants are the mainstay of ADHD treatment, their use is marred by concerns about substance abuse. This study involving  37 adults with ADHD looks at whether naltrexone might...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe